Patents/Assignees

Atai Therapeutics, Inc.

13 patents in portfolio

US12606525utility2026
Dimethyltryptamine Analogues as Nitric Oxide Delivery Drugs
0 cites
US12472163utility2025
Compositions of Matter and Pharmaceutical Compositions
0 cites
US12396982utility2025
Compositions of Matter and Pharmaceutical Compositions
0 cites
US12378194utility2025
N, N-dimethyltryptamine Salts and Crystalline Salt Forms
0 cites
US12351537utility2025
Dimethoxyphenylalkylamine Activators of Serotonin Receptors
0 cites
US12343319utility2025
Compositions and Methods for Treatment of Diseases and Disorders
0 cites
US12344570utility2025
Aminotetraline Activators of Serotonin Receptors
0 cites
US12128027utility2024
N—n-dimethyltryptamine (DMT) and DMT Analog Compositions, Methods of Making, and Methods of Use Thereof
0 cites
US12097332utility2024
Systems, Devices, and Methods for Generating and Manipulating Objects in a Virtual Reality or Multi-sensory Environment to Maintain a Positive State of a User
0 cites
US12065405utility2024
Prodrugs and Conjugates of Dimethyltryptamine
0 cites
US12016866utility2024
Methods and Compositions for Potentiating the Action of Opioid Analgesics Using Iboga Alkaloids
0 cites
US12012381utility2024
Dimethyltryptamine Analogues as Nitric Oxide Delivery Drugs
0 cites
US11926574utility2024
Dimethoxyphenylalkylamine Activators of Serotonin Receptors
0 cites